DOSE.CN - Rapid Dose Therapeutics Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.7000
0.0000 (0.00%)
At close: 11:21AM EDT
Stock chart is not supported by your current browser
Previous Close0.7000
Open0.7100
Bid0.5300 x 0
Ask0.7000 x 0
Day's Range0.7000 - 0.7000
52 Week Range0.0750 - 1.3300
Volume10,500
Avg. Volume30,042
Market Cap52.515M
Beta (3Y Monthly)-29.32
PE Ratio (TTM)N/A
EPS (TTM)-0.1820
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Rapid Dose Therapeutics Announces Commercialization of QuickStrip™ Oral Thin Strips
    PR Newswire6 days ago

    Rapid Dose Therapeutics Announces Commercialization of QuickStrip™ Oral Thin Strips

    Licensee, Chemesis International Inc., begins efforts for distribution of QuickStrip ™ across United States & Puerto Rico BURLINGTON, ON , June 13, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. ("RDT" ...

  • Rapid Dose Therapeutics Appoints Vice President, Research & Innovation
    PR Newswire13 days ago

    Rapid Dose Therapeutics Appoints Vice President, Research & Innovation

    BURLINGTON, ON, June 6, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), a Canadian leader in drug delivery solutions, is pleased to announce that Dr. Rina Carlini has been appointed Vice President, Research & Innovation. Dr. Carlini is an accomplished scientist and management executive with 25 years of experience in technology innovation, product development, commercialization within the sectors of health technology, life science, IoT, artificial intelligence, advanced manufacturing, and nanotechnology. Dr. Carlini holds a Ph.D. in Chemistry from the University of Waterloo, and in 2017 she was awarded the Faculty of Science Alumni of Honour.

  • Rapid Dose Therapeutics and TFB & Associates Ltd. Sign Agreement for the Sale and Distribution of Innovative Quickstrip™ Nutraceutical Product Line Across Canada
    PR Newswire2 months ago

    Rapid Dose Therapeutics and TFB & Associates Ltd. Sign Agreement for the Sale and Distribution of Innovative Quickstrip™ Nutraceutical Product Line Across Canada

    BURLINGTON, ON , April 16, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") ( CSE: DOSE ), a Canadian life sciences company focused on innovative drug and ...

  • Rapid Dose Therapeutics Appoints Chief Financial Officer and Provides Business Update
    CNW Group2 months ago

    Rapid Dose Therapeutics Appoints Chief Financial Officer and Provides Business Update

    BURLINGTON, ON , April 10, 2019 /CNW/ - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), a Canadian leader in drug delivery solutions,  is pleased to announce that Mr. Ian Fodie has been appointed Chief Financial Officer effective immediately. Mr. Fodie replaces Mr. Lino Fera , as part of the planned transition process following the Company's public listing in December 2018 . Mr. Fodie graduated from the University of Otago, New Zealand , with a Bachelor of Commerce degree, obtained his professional designation from the New Zealand Institute of Chartered Accountants, and has now resided in Canada for over 30 years.

  • Newsfile3 months ago

    Rapid Dose Therapeutics and Thrive Cannabis Sign MOU to Provide Quickstrip(TM) Oral Thin Strips Under a White Label Manufacturing Agreement

    Burlington, Ontario--(Newsfile Corp. - March 13, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Memorandum of Understanding ("MOU") February 27, 2019 with THRIVE Cannabis ("THRIVE") providing THRIVE the rights to sell oral thin film strips with RDT's proprietary QuickStrip™ technology using cannabis distillates provided by THRIVE and by ...

  • Newsfile3 months ago

    Rapid Dose Therapeutics Corp. Grants Stock Options

    Burlington, Ontario--(Newsfile Corp. - March 11, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Corporation") announces the grant of options to directors, officers, eployess and consultants to purchase 4,526,000 common shares of the Corporation, exercisable at $0.82 per share at any time on or before March 11, 2024. The grants are subject to the terms of RDT's stock option plan. In accordance with securities regulatory requirements, any shares issued pursuant to ...

  • Newsfile3 months ago

    Rapid Dose Therapeutics Wins Summary Judgment Against CTT Pharmaceuticals. CTT's Case Is Dismissed

    Burlington, Ontario--(Newsfile Corp. - March 5, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has been successful in obtaining a summary judgment against CTT Pharmaceutical Holdings, Inc. ("CTT") dismissing CTT's lawsuit against RDT. Justice E.M. Morgan of the Ontario Superior Court of Justice wrote in the Court's decision, "There is no ...

  • Newsfile4 months ago

    Rapid Dose Therapeutics Enters Into Advisory Agreement with Spinnaker Capital Markets

    Burlington, Ontario--(Newsfile Corp. - February 14, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT") is pleased to announce that it has appointed Spinnaker Capital Markets Inc. ("Spinnaker") as its capital markets and investor relations advisor. Spinnaker is a Toronto-based advisory firm which provides public companies with an array of services tailored to raise capital, target and attract institutional and retail investors, increase shareholder value and focus on developing and expanding the network of investors, analysts ...

  • Newsfile5 months ago

    Rapid Dose Therapeutics Announces Appointment of Dr. Gabriela Radulescu as Medical Director

    Burlington, Ontario--(Newsfile Corp. - January 23, 2019) - Rapid Dose Therapeutics  (CSE: DOSE) ("RDT") is pleased to announce the appointment of Dr. Gabriela Radulescu as Medical Director for RDT.Dr. Radulescu is a physician with 20 years of experience in the pharmaceutical industry. She brings to the RDT team strong strategic and operational medical leadership that will enhance the dialogue with pharmaceutical companies wanting to offer QuickStrip™ technology to their patient base. Dr. Radulescu has ...

  • Newsfile5 months ago

    Rapid Dose Therapeutics Announces Launch of Its Innovative QuickStrip(TM) Product to the Nevada Cannabis Market Through Brand Partnership with Flower One

    Burlington, Ontario--(Newsfile Corp. - January 15, 2019) - Rapid Dose Therapeutics Inc. (CSE: DOSE) ("RDT") is pleased to announce its entered into a definitive agreement (the "Agreement") on January 10, 2019, with Flower One Holdings Inc. (CSE: FONE) (OTCQB: FLOOF)("Flower One") pursuant to which Flower One has been granted license to manufacture, distribute and sell RDT's QuickStrip™, an innovative, proprietary delivery technology for the cannabis market in Nevada. Flower One expects to produce ...

  • Newsfile6 months ago

    CSE New Listing - Rapid Dose Therapeutics Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

    Vancouver, British Columbia--(Newsfile Corp. - December 18, 2018) -   Rapid Dose Therapeutics (CSE: DOSE) is one of the latest new listing on the Canadian Securities Exchange, following a reverse takeover of TSX Venture Exchange listed Acme Resources. The company, through its subsidiaries, provides proprietary enhanced drug delivery technologies.InvestmentPitch Media has produced a "video" which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Rapid ...

  • Newsfile6 months ago

    Rapid Dose Therapeutics and Aphria to Deliver Innovative QuickStrip(TM) Technology to the German Cannabis Market

    Burlington, Ontario and Leamington, Ontario--(Newsfile Corp. - December 18, 2018) - Rapid Dose Therapeutics Inc. (CSE: DOSE) ("RDT" or the "Company")  and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) announced today that they have expanded the scope of their previously announced agreement (the "Agreement"), executed on November 1, 2018 (see the Company's press release dated November 5, 2018), expanding the territory where Aphria has been granted exclusive preferred rights to license, manufacture, ...

  • Aphria and Rapid Dose Therapeutics to Introduce Innovative QuickStrip™ Oral Thin Strips to German Cannabis Market
    CNW Group6 months ago

    Aphria and Rapid Dose Therapeutics to Introduce Innovative QuickStrip™ Oral Thin Strips to German Cannabis Market

    LEAMINGTON , ON and BURLINGTON, ON , Dec. 18, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) and Rapid Dose Therapeutics Inc. ("RDT") (CSE: DOSE) announced today that they have expanded the scope of their previously announced agreement (the "Agreement") expanding the territory where Aphria has been granted exclusive preferred rights to license, manufacture, distribute and sell RDT's QuickStrip™ innovative, proprietary delivery technology for the cannabis market to Germany . " Germany is one of the most sought-after cannabis markets today, and Aphria continues to take a comprehensive approach to ensure a leading presence in the country as the opportunity evolves," said Jakob Ripshtein, President of Aphria.

  • Newsfile6 months ago

    Rapid Dose Therapeutics Begins Trading on the CSE Under the Ticker "DOSE"

    Burlington, Ontario--(Newsfile Corp. - December 17, 2018) -  Rapid Dose Therapeutics Corp. (formerly ACME Resources Corp.) (CSE: DOSE) ("RDT" or the "Corporation") is pleased to announce that, following completion of the business combination with Rapid Dose Therapeutics Inc., the Corporation's Common Shares will commence trading on the Canadian Securities Exchange (the "CSE") under the four-letter ticker symbol "DOSE" effective as of the opening of the market today.RDT's CEO, Mark Upsdell, commented that, "The RDT ...